Antimicrobial Stewardship

April 15th 2025

In a phase 3 study, GSK’s gepotidacin demonstrated 92% efficacy against the sexually transmitted infection (STI).

April 13th 2025

A surge in invasive group A Streptococcal (IGAS) infections in children marked by more virulent strains followed a reduction in cases coinciding with protective measures for the pandemic.

April 10th 2025

Study shows benefit using antibiotic earlier in clinical care for gram-negative infections.

April 8th 2025

Although the TB pipeline has several new agents in various phases, challenges to antimicrobial development remain. Therefore treatment adherence remains paramount.